- Home
- HSII vs HUMA Comparison
HSII vs HUMA Comparison
Compare HSII & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSII
- HUMA
- Stock Information
- Founded
- HSII 1953
- HUMA 2004
- Country
- HSII United States
- HUMA United States
- Employees
- HSII N/A
- HUMA N/A
- Industry
- HSII Diversified Commercial Services
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- HSII Consumer Discretionary
- HUMA Health Care
- Exchange
- HSII Nasdaq
- HUMA Nasdaq
- Market Cap
- HSII 753.6M
- HUMA 629.0M
- IPO Year
- HSII 1999
- HUMA N/A
- Fundamental
- Price
- HSII $38.76
- HUMA $4.86
- Analyst Decision
- HSII Buy
- HUMA Strong Buy
- Analyst Count
- HSII 2
- HUMA 7
- Target Price
- HSII $38.50
- HUMA $11.00
- AVG Volume (30 Days)
- HSII 105.0K
- HUMA 3.3M
- Earning Date
- HSII 10-28-2024
- HUMA 11-07-2024
- Dividend Yield
- HSII 1.58%
- HUMA N/A
- EPS Growth
- HSII N/A
- HUMA N/A
- EPS
- HSII 1.84
- HUMA N/A
- Revenue
- HSII $1,060,145,000.00
- HUMA N/A
- Revenue This Year
- HSII $5.95
- HUMA N/A
- Revenue Next Year
- HSII $2.94
- HUMA $3,831.37
- P/E Ratio
- HSII $20.65
- HUMA N/A
- Revenue Growth
- HSII 5.86
- HUMA N/A
- 52 Week Low
- HSII $22.52
- HUMA $1.96
- 52 Week High
- HSII $41.94
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- HSII 59.19
- HUMA 37.63
- Support Level
- HSII $36.49
- HUMA $5.57
- Resistance Level
- HSII $37.59
- HUMA $5.81
- Average True Range (ATR)
- HSII 0.79
- HUMA 0.49
- MACD
- HSII 0.11
- HUMA 0.01
- Stochastic Oscillator
- HSII 91.90
- HUMA 19.12
About HSII Heidrick & Struggles International Inc.
Heidrick & Struggles International Inc is a leadership advisory firm providing executive search and consulting services to businesses and business leaders world wide. The company's operating segments includes the executive search business which operates in the Americas; Europe; Asia Pacific and On-Demand Talent and Heidrick Consulting. It generates maximum revenue from the Americas.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.